Incidence rate ratio for all-cause mortality 0.70 during peak of 1918 H1N1 flu, early COVID-19
FRIDAY, Aug. 14, 2020 (HealthDay News) — Excess mortality during the peak of the 1918 H1N1 influenza pandemic was comparable to that seen early in the COVID-19 pandemic outbreak in New York City, according to a research letter published online Aug. 13 in JAMA Network Open.
Jeremy Samuel Faust, M.D., from Brigham and Women’s Hospital in Boston, and colleagues compared all-cause mortality in New York City during the peak of the 1918 H1N1 influenza pandemic and the early COVID-19 outbreak. The incidence rate per person-months was calculated for October and November (61 days) from 1914 through 1918 and for March 11 through May 11, 2020 (61 days).
The researchers identified 31,589 all-cause deaths among 5,500,000 residents during the peak of the 1918 H1N1 influenza outbreak in New York City (incident rate, 287.17 deaths per 100,000 person-months). The incidence rate ratio for all-cause mortality was 2.80 during the H1N1 influenza pandemic versus the corresponding periods from 1914 to 1917. During the early COVID-19 outbreak, there were 33,465 all-cause deaths among 8,280,000 residents (incident rate, 202.08 deaths per 100,000 person-months). The incident rate ratio for all-cause mortality was 4.15 during the study period of 2020 compared with the corresponding periods of 2017 through 2019. The incidence rate ratio for all-cause mortality was 0.70 during the peak of the 1918 H1N1 influenza pandemic and the early COVID-19 outbreak.
“We believe that our findings may help officials and the public contextualize the unusual magnitude of the COVID-19 pandemic,” the authors write.
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay
AAP Releases Influenza Vaccine Recommendations for All Children 6 Months and Older
Most U.S. Adults Unsure Which Vaccines CDC Recommends During Pregnancy
Updated COVID-19 Shot Beneficial for Those With Autoimmune Rheumatic Disease
Trends Reported in Vaccination Coverage for Adolescents for 2025
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season
Pregnancy Complications Rare for Women Receiving CAR T-Cell Therapy